semaglutide cease and desist π¨ NEWS: Here is a copy of a letter sent out by Novo Nordisk to an unknown number of telehealth companies on Friday. Medical Spas and Compounding pharmacies Ozempic's patent problem: how Novo
Description
Yes and no
Jan 31, 2026 A chart titled "GLP1 Side Effects & Solutions," listing various side effects and corresponding solutions
Cardiologists didn't expect this from a weight loss drug
Your immune system can age the rest of you faster
Leaders across healthcare are emphasizing pairing these medications with lifestyle interventions, especially as emerging data points to kidney and cardiovascular benefits
Looking for the best electrolytes for GLP-1 users
